- Home
- MGTX
MGTX
MeiraGTx Holdings plc
as 04-18-2025 1:39pm EST
| Founded: | 2015 | Country: | United States |
| Employees: | N/A | City: | NEW YORK |
| Market Cap: | N/A | IPO Year: | N/A |
| Target Price: | $24.50 | AVG Volume (30 days): | 687.8K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -2.12 | EPS Growth: | N/A |
| 52 Week Low/High: | $3.85 - $8.75 | Next Earning Date: | 05-08-2025 |
| Revenue: | $33,279,000 | Revenue Growth: | 137.42% |
| Revenue Growth (this year): | 468.38% | Revenue Growth (next year): | 19.26% |
Stock Insider Trading Activity of MeiraGTx Holdings plc (MGTX)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Giroux Richard | MGTX | CFO & COO | Jan 21 '25 | Sell | $6.29 | 24,000 | $150,960.00 | 849,947 |
Latest MeiraGTx Holdings plc News
MGTX Breaking Stock News: Dive into MGTX Ticker-Specific Updates for Smart Investing
Zacks
9 days ago
Beam Therapeutics (BEAM) Moves 12.6% Higher: Will This Strength Last?
Simply Wall St.
10 days ago
US High Growth Tech Stocks to Watch in 2023
TipRanks
18 days ago
Biotech stocks slide as Marks resignation seen being negative for sector
Zacks
25 days ago
AnaptysBio (ANAB) Moves 9.5% Higher: Will This Strength Last?
Simply Wall St.
a month ago
MeiraGTx Holdings plc (NASDAQ:MGTX) Is Expected To Breakeven In The Near Future
Insider Monkey
a month ago
MeiraGTx Holdings (MGTX) Partners with Hologen for $200M AI-Powered Parkinson’s Treatment
MT Newswires
a month ago
RBC Raises Price Target on MeiraGTx Holdings to $13 From $11, Keeps Outperform, Speculative Risk
Pharmaceutical Technology
a month ago
MeiraGTx and Hologen launch AI-backed gene therapy venture
Compare MGTX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "MGTX MeiraGTx Holdings plc - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.